Table 1.

Demographic and clinical data of control (C), HBV infected (HBV), hepatocellular carcinoma (HCC) and HBV-related HCC (HBV+HCC) groups.

Parameters	C, N (%)	HBV, N (%)	HCC, N (%)	HBV+HCC, N (%)	P
Age (years)	Mean age	Mean age	Mean age	Mean age	P=0.161
	33±6.216	53.85±9.582	55.44±10.305	57.13±9.819	F=1.740
	Age range	Age range	Age range	Age range
	37-61	31-71	30-72	37-72
	Median	Median	Median	Median
	51.50 years	58 years	56 years	59 years
Sex
Male	24(80.0)	28(70.0)	32(78.0)	29(72.5)
Female	6(20.0)	12(30.0)	9(22.0)	11(27.5)	P=0.738
Hepatocellular carcinoma:	-	-
Well or moderately differentiated			37(90.2)	35(87.5)
Poorly differentiated			4(9.8)	5(12.5)
HCC grading:		-
Early			39(95.1)	38(95.0)
G1	-		1(2.4)	2(5.0)
G2-G3			1(2.4)	0
Total bilirubin (μ mol/l)	15.43±5.65	18.76±6.75	28.45±12.24	33.10±11.77
ALT (U/I)	26.23±10.90	45.76±32.03	88.25±95.32	117.76±102.54
AFP (ng/mL)	2.12±1.14	3.12±2.79	421.21±104.33	534.54±420.76
Serum HBV DNA level	-	7.6±0.8	-	7.8±0.1
Mean, log IU/mL (1SD)
HBs-Ag positive	-	40(100.0)	-	40(100.0)
HBe-Ab positive	-	12(30.0)	-	15(37.5)